HR · Healthcare Realty Trust Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| % of Cash NOI in Company's Top 20 Markets | 77% | Q2 2026 | — |
| Cash leasing spreads | 4.8% | second quarter 2026 | — |
|
|
|||
| Cash leasing spreads (renewals) | 4.8% | Q2 2026 | — |
| FAD non-GAAP | 109.4M | second quarter 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Normalized FFO 143.7M
+789K Non-real estate depreciation and amortization
+1.38M Non-cash interest amortization, net
-13.72M Straight-line amortization, net
+4.42M Stock-based compensation
-164K Unconsolidated JV non-cash items
-27.05M Maintenance capex
= FAD 109.36M
|
|||
| FAD payout ratio non-GAAP | 76% | second quarter 2026 | — |
|
|
|||
| Fully Diluted Shares and Units | 346.96M | Q2 2026 | — |
| Lease executions | 1.5M | Second quarter 2026 | — |
|
|
|||
| Net Debt to Enterprise Value | 37% | Q2 2026 | — |
| New lease executions | 350,000 | second quarter 2026 | — |
|
|
|||
| Number of markets | 49 | Q2 2026 | — |
|
|
|||
| Number of properties | 562 | Q2 2026 | — |
|
|
|||
| Same store cash NOI growth | 5.1% | second quarter 2026 | — |
|
|
|||
| Shares repurchased | 3.8M | second quarter 2026 | — |
| Tenant retention | 88.5% | second quarter 2026 | — |
|
|
|||
| Tenant retention rate (renewals) | 88.5% | Q2 2026 | — |
| Total portfolio occupancy | 90.7% | Q2 2026 | — |
|
|
|||
| Total Properties | 562 | Q2 2026 | — |
|
|
|||
| Total Square Feet | 32.8M | Q2 2026 | — |
|
|
|||
| % of Cash NOI in Top 20 Markets non-GAAP | 77% | Q1 2026 | — |
| % Variable Rate Debt | 7.2% | 1Q 2026 | — |
| Adjusted EBITDA non-GAAP | $184.83M | 1Q 2026 | — |
GAAP → non-GAAP reconciliationGAAP EBITDA 181.32M
+937K Transaction costs
-10.78M Gain on sales of assets
+16K Impairments on real estate assets
+5.84M Restructuring and severance-related charges
+21K Loss on extinguishment of debt
+2.6M Timing impact
+3.93M Stock based compensation
+96K Debt financing costs
+507K Other
+339K Unconsolidated JV adjustments
= Adjusted EBITDA 184.83M
|
|||
| Annualized Adjusted EBITDA non-GAAP | $739.31M | 1Q 2026 | — |
| Capitalized interest | $3.47M | 1Q 2026 | — |
| Leverage ratio | 38.1% | 1Q 2026 | — |
| New and renewal leases executed | 291 | Q1 2026 | — |
| New lease commitments as a % of annual net rent | 46.9% | 1Q 2026 | — |
| New leases SF | 286,314 | 1Q 2026 | — |
| Renewal commitments as a % of annual net rent | 13% | 1Q 2026 | — |
| Renewals SF | 1,725,651 | 1Q 2026 | — |
| Same store cash NOI | $161.08M | 1Q 2026 | — |
|
|
|||
| Same store number of properties | 529 | 1Q 2026 | — |
| Same store occupancy | 92.3% | 1Q 2026 | — |
| Secured leverage ratio | 0.2% | 1Q 2026 | — |
| Share of Unconsolidated JV Net Debt | $34.03M | 1Q 2026 | — |
| Square feet | 32,883,258 | 1Q 2026 | — |
| Total development budget | $106.2M | 1Q 2026 | — |
| Total development cost to complete | $13.04M | 1Q 2026 | — |
| Total development leased % | 60% | 1Q 2026 | — |
| Total development square feet | 224,270 | 1Q 2026 | — |
| Total lease executions SF | 2,011,965 | 1Q 2026 | — |
| Total leasing commitments as a % of annual net rent | 16.1% | 1Q 2026 | — |
| Total liquidity | $1.22B | 1Q 2026 | — |
| Total redevelopment budget | $287.7M | 1Q 2026 | — |
| Total redevelopment cost to complete | $183.93M | 1Q 2026 | — |
| Total redevelopment count | 23 | 1Q 2026 | — |
| Total redevelopment project leased % | 64% | 1Q 2026 | — |
| Total redevelopment project square feet | 1,434,891 | 1Q 2026 | — |
| Total redevelopment square feet | 2,070,746 | 1Q 2026 | — |
| Total shares and OP units outstanding | 350,785,034 | 1Q 2026 | — |
| Unencumbered leverage ratio | 41.8% | 1Q 2026 | — |
| WALT (months) - Occupied | 64.5 | 1Q 2026 | — |
| WALT (months) - Total | 94.3 | 1Q 2026 | — |
| Asset sales | $1.2B | Full year 2025 (through February 2026) | — |
| Average annual escalators | 3% | Q4 2025 | — |
| Blended cap rate | 6.7% | Full year 2025 (through February 2026) | — |
| Commercial paper program size | $600M | February 12, 2026 | — |
| Diluted WA shares outstanding | 354.9M | 4Q 2025 | — |
| Enterprise value | $10.1B | as of 12/31/25 | — |
| Lease executions square feet | 5.8M | Full year 2025 | — |
| Leases executed | 292 | Q4 2025 | — |
| Liquidity | $1.4B | Q4 2025 | — |
| Market capitalization | $6B | as of 12/31/25 | — |
| New lease executions square feet | 1.6M | Full year 2025 | — |
| NOI in Top 15 Markets | 65% | 4Q 2025 | — |
| Number of disposition transactions | 34 | Full year 2025 (through February 2026) | — |
| Number of properties (Total) | 562 | 4Q 2025 | — |
| Period end occupancy | 92.1% | 4Q 2025 | — |
| Properties | 562 | 4Q 2025 | — |
| Repaid senior notes | $250M | Full year 2025 | — |
| Repaid term loans | $650M | Full year 2025 | — |
| Revenue per occ SF non-GAAP | $38.31 | 4Q 2025 | — |
| Run-rate G&A expense reduction | $10M | Full year 2025 | — |
| Same store Cash NOI Margin non-GAAP | 64.4% | 4Q 2025 | — |
| Share repurchase average price | $17.27 | January 2026 | — |
| Share repurchase total | $50M | January 2026 | — |
| Shares/units outstanding | 355.9M | as of 12/31/25 | — |
| Term loans repaid in fourth quarter | $542M | Q4 2025 | — |
| Total cash NOI non-GAAP | $178.46M | 4Q 2025 | — |
| Total shares outstanding | 355,878,607 | As of December 31, 2025 | — |
| Total square footage | 32.7M | 4Q 2025 | — |
| Weighted average lease term | 6.2 | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HR
this stock
Healthcare Realty Trust Inc
|
$6.56B | +12.9% | -6.9% | — | 5.0% |
|
WELL
Welltower Inc.
|
$170.52B | +29.1% | +35.6% | 120.2 | 2.5% |
|
VTR
Ventas, Inc.
|
$47.96B | +20.0% | +18.5% | 173.2 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.66B | +32.0% | +4.5% | 60.7 | 3.3% |
|
OHI
Omega Healthcare Investors Inc
|
$14.25B | +4.4% | +13.2% | 16.7 | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HR | -1.4% | -11.2% | +4.0% | -9.0% | +12.9% |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | -2.6% | -15.1% | -10.7% | -12.2% | -0.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.